FDA Cuts Sample Size in Narcolepsy Trial, AVDL Stock Goes Flying
It’s only Monday, but Avadel Pharmaceuticals (NASDAQ:AVDL) is already making headlines. AVDL stock is soaring after the pharmaceutical company said the FDA cut its sample size in one of its trials. Here’s everything we know. ... [Read]